Kimia Biosciences share price
You have to be logged in to add this to Watchlist.- ₹70.94(-0.31%)July 7, 2025 15:27:55 PM IST
- NSE
- BSE
- Vol : 35.97K (NSE + BSE)Last 20 day avg : 34.77 K
Kimia Biosciences is trading -0.31% lower at Rs 70.94 as compared to its last closing price. Kimia Biosciences has been trading in the price range of 73.49 & 67.61. Kimia Biosciences has given 55.88% in this year & 16.27% in the last 5 days. Kimia Biosciences has TTM P/E ratio 20.94 as compared to the sector P/E of 23.19.The company posted a net profit of 1.99 Crores in its last quarter.Listed peers of Kimia Biosciences include Sms Lifesciences India (0.27%), Medico Remedies (-1.45%), Kimia Biosciences (-0.31%).The Mutual Fund holding in Kimia Biosciences was at 0.38% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Kimia Biosciences was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jul 07, 2025, 07:32 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values33.78The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values35.05Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.16Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry3.93The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 26.21% from Rs 38.24 crore to Rs 30.30 crore, year-on-year
- The company has grown its March quarter profit by 10.94% from Rs 1.80 crore to Rs 1.99 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 86.19
- R2
- 98.95
- R3
- 111.04
- S1
- 61.34
- S2
- 49.25
- S3
- 36.49
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sms Lifesciences India | Neutral | 1,196.75 | 0.27 | 361.81 | 17.67 | 1.81 | 0.13 | 10.18 |
| Medico Remedies | Bearish | 41.60 | -1.45 | 342.86 | 33.82 | 5.48 | - | 0.59 |
| Kimia Biosciences | Bullish | 70.94 | -0.31 | 336.40 | 35.24 | 33.96 | - | 170.33 |
| Everest Organics | Neutral | 340.00 | 0.56 | 330.15 | - | 3.95 | - | 13.15 |
| Trident Lifeline | Moderately Bearish | 271.00 | 0.37 | 311.63 | 26.42 | 4.82 | - | 50.07 |
- Promoter(s) holds a high stake in the company at 74.94%
- FIIs are not invested in this company
- Mutual Funds holding is constant over the last quarter at 0.38%
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-26 | Audited Results |
| 2025-05-05 | Others |
| 2025-04-23 | Others |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE285U01025
- BSE Code530313
- NSE Code
Kimia Biosciences is trading at 70.94 as on Mon Jul 07 2025 09:57:55. This is -0.31% lower as compared to its previous closing price of 71.16.
The market capitalization of Kimia Biosciences is 336.40 Cr as on Mon Jul 07 2025 09:57:55.
The 52 wk high for Kimia Biosciences is 86.85 whereas the 52 wk low is 35.10
Kimia Biosciences can be analyzed on the following key metrics -
- TTM P/E: 20.94
- Sector P/E: 23.19
- Dividend Yield: 0.00%
- D/E ratio: 3.93
Kimia Biosciences reported a net profit of 9.61 Cr in 2025.
The Mutual Fund Shareholding was 0.38% at the end of 31 Mar 2025.